949 related articles for article (PubMed ID: 33894490)
21. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
[TBL] [Abstract][Full Text] [Related]
24. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
AboulWafa OM; Daabees HMG; Badawi WA
Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
26. Quinazoline Based HSP90 Inhibitors: Synthesis, Modeling Study and ADME Calculations Towards Breast Cancer Targeting.
El-Shafey HW; Gomaa RM; El-Messery SM; Goda FE
Bioorg Med Chem Lett; 2020 Aug; 30(15):127281. PubMed ID: 32527460
[TBL] [Abstract][Full Text] [Related]
27. New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study.
El Azab IH; El-Sheshtawy HS; Bakr RB; Elkanzi NAA
Molecules; 2021 Jan; 26(3):. PubMed ID: 33573040
[TBL] [Abstract][Full Text] [Related]
28. Novel 1,2,4-triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studies.
Turky A; Sherbiny FF; Bayoumi AH; Ahmed HEA; Abulkhair HS
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000170. PubMed ID: 32893368
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents.
Genc M; Karagoz Genc Z; Tekin S; Sandal S; Sirajuddin M; Hadda Taibi B; Sekerci M
Acta Chim Slov; 2016 Dec; 63(4):726-737. PubMed ID: 28004087
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines.
Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM
Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828
[TBL] [Abstract][Full Text] [Related]
31. Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and
Eldehna WM; Al-Rashood ST; Al-Warhi T; Eskandrani RO; Alharbi A; El Kerdawy AM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):270-285. PubMed ID: 33327806
[TBL] [Abstract][Full Text] [Related]
32. From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity.
El-Shershaby MH; Ghiaty A; Bayoumi AH; Al-Karmalawy AA; Husseiny EM; El-Zoghbi MS; Abulkhair HS
Bioorg Med Chem; 2021 Jul; 42():116266. PubMed ID: 34126285
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
[TBL] [Abstract][Full Text] [Related]
34. Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.
Oubella A; El Mansouri AE; Fawzi M; Bimoussa A; Laamari Y; Auhmani A; Morjani H; Robert A; Riahi A; Youssef Ait Itto M
Bioorg Chem; 2021 Oct; 115():105184. PubMed ID: 34333421
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of New Benzimidazole-1,2,3-triazole Hybrids as Tyrosinase Inhibitors.
Mahdavi M; Ashtari A; Khoshneviszadeh M; Ranjbar S; Dehghani A; Akbarzadeh T; Larijani B; Khoshneviszadeh M; Saeedi M
Chem Biodivers; 2018 Jul; 15(7):e1800120. PubMed ID: 29766648
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents.
Goud NS; Pooladanda V; Mahammad GS; Jakkula P; Gatreddi S; Qureshi IA; Alvala R; Godugu C; Alvala M
Chem Biol Drug Des; 2019 Sep; 94(5):1919-1929. PubMed ID: 31169963
[TBL] [Abstract][Full Text] [Related]
37. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer.
Abdel-Mohsen HT; Abd El-Meguid EA; El Kerdawy AM; Mahmoud AEE; Ali MM
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900340. PubMed ID: 32045054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]